TherapeuticsMD, Inc. (TXMD) stock
TXMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 12/3026% below fair value
$1.91+0.10 (+5.52%)
Close on Nov 17, 2026Market cap $22.11MP/E –Yield –
TherapeuticsMD market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
TherapeuticsMD's market cap was $21.41M on Nov 11, 2026, against $19.68M a year earlier. Over the last 5 years it ranged from $9.92M to $163.36M, with a median of $25.00M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $21.41M | +13.5% |
| 2025 | Dec 31, 2025 | $18.87M | +90.2% |
| 2024 | Dec 31, 2024 | $9.92M | -58.3% |
| 2023 | Dec 29, 2023 | $23.79M | -55.0% |
| 2022 | Dec 30, 2022 | $52.92M | -65.4% |
| 2021 | Dec 31, 2021 | $152.96M | -53.7% |
| 2020 | Dec 31, 2020 | $330.10M | -43.5% |
| 2019 | Dec 31, 2019 | $583.89M | -35.2% |
| 2018 | Dec 31, 2018 | $900.93M | -31.1% |
| 2017 | Dec 29, 2017 | $1.31B | +15.2% |
| 2016 | Dec 30, 2016 | $1.13B | -38.5% |
| 2015 | Dec 31, 2015 | $1.84B | +165.5% |
| 2014 | Dec 31, 2014 | $694.34M | -8.1% |
| 2013 | Dec 31, 2013 | $755.26M | +209.9% |
| 2012 | Dec 31, 2012 | $243.68M | +177.4% |
| 2011 | Dec 30, 2011 | $87.86M | – |
See a number that looks wrong?